Bradley Michael Haverkos MD

Physician

1665 Aurora CtFl 2Aurora, CO 80045
Phone+1 720-848-8698
Fax+1 720-848-1786

Dr. Haverkos is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Haverkos' full profile Already have an account?

Education & Training

Ohio State University College of MedicineM.M.S., 2013 - 2015
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2012 - 2015
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2009 - 2012
Wright State UniversityM.P.H., 2005 - 2009
Wright State University Boonshoft School of MedicineClass of 2009

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NM State Medical License 2020 - 2028
CO State Medical License 2015 - 2027
KS State Medical License 2021 - 2027
WY State Medical License 2020 - 2027
NE State Medical License 2020 - 2026
OH State Medical License 2012 - 2016
IL State Medical License 2009 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Boonshoft Physician Leadership Development Scholarship Wright State University, 2009
Outstanding Senior Medical Student in Internal Medicine 2009
College of Arts and Science Scholarship Miami University, 2002

Publications & Presentations

PubMed

Analysis of CD8 Cytotoxic T-Cells in Patients With Myelodysplastic Neoplasms and T-Cell Large Granulocyte Lymphocytic Leukemia.
Makenna May, Nathaly Limon De la Rosa, Cassandra Duarte, Grace Boosma, Diana Abbott
European Journal of Haematology. 2026-11-01
Feasibility and Safety of a Novel CD19-Directed CAR T-Cell Therapy in Patients with R/R B-Cell Non-Hodgkin Lymphoma.
Steven M Bair, Navin Pinto, Andrew Roth, Michael Verneris, Bradley Haverkos
Transplantation and Cellular Therapy. 2026-10-01
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.
Cassandra Duarte, Grace N Bosma, Diana Abbott, Gaston Jean-Louis, Maciej Kabat
European Journal of Haematology. 2026-09-18

Journal Articles

Epstein-Barr Virus Type-2 Infects T-cells and Induces B-cell Lymphomagenesis in Humanized Mice
Bradley Haverkos, Zenggang Pan, mBio
Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas
Haverkos, B., Huang, Y., Gru, A., Pancholi, P., Freud, A., Mishra, A., Ruppert, A., Baiocchi, R., & Porcu, P., IJC, 1/1/2017
A single center's experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation
Haverkos, B. Huang, Y., Elder, P., O’Donnell, L., Scholl, D., Whittaker, B., Vasu, S., Penza, S., Andrtisos, L., Devine, S., & Jaglowski, S., BMT, 1/1/2017

Abstracts/Posters

Dose Reduction or Omission of Vinca Alkaloids during Initial Chemotherapy Treatment Does Not Impact Outcomes in Patients with Lymphoma
Brad M. Haverkos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refracto...
Brad M. Haverkos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Final Results of Phase 1/1b Study of Tenalisib, Dual PI3K _/_ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma
Brad M. Haverkos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

CNS Lymphoma
1/28/2017
Cutaneous Lymphomas
University of Colorado - 1/24/2017
Aggressive Non-Hodgkin Lymphoma.
1/13/2017

Other

Benefit Design of Medicare Drug Plans: An Analysis of Ohio and the National Landscape from 2006 through 2009.
Haverkos, B., Part of Community Health and Preventative Medicine Commons
http://corescholar.libraries.wright.edu/mph/20
1/1/2009
Langerhans Cell Histiocytosis.
Haverkos, B. & Light, D., Medpix Medical Image Database. Atlas, and Teaching File (electronic)
http://rad.usuhs.edu/medpix/tf_case.html?mode=tf_case&pt_id=11573
1/1/2007

Press Mentions

$Viracta Therapeutics Announces Final Phase 1b/2 Data Showing Promising and Durable Signal of Efficacy for Nana-Val in Relapsed/Refractory Epstein-Barr Virus-Positive Lymphoma in an Oral Presentation at ASH 2021$
Viracta Therapeutics Announces Final Phase 1b/2 Data Showing Promising and Durable Signal of Efficacy for Nana-Val in Relapsed/Refractory Epstein-Barr Virus-Positive Lymphoma in an Oral Presentation at ASH 2021December 13th, 2021
The Making of a Model for AMLDecember 3rd, 2018